Roger Federer Foundation Partners with OneSight EssilorLuxottica Foundation to Bring Vision Care to Thousands of Zambian Schoolchildren 27-10-2025, 17:28

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00

FIFA Extends Long-Standing Integrity Partnership With Sportradar 2-03-2026, 16:28